Cue Biopharma
CUE
CUE
45 hedge funds and large institutions have $51.3M invested in Cue Biopharma in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 2 closing their positions.
Holders
45
Holders Change
+8
Holders Change %
+21.62%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
21
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SPC
1
Slate Path Capital
New York
|
$7.5M |
2 |
6CM
2
683 Capital Management
New York
|
$2.53M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$6.37M |
4 |
4
BlackRock
New York
|
$10.3M |
5 |
5
HSBC Holdings
London,
United Kingdom
|
$574K |